Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDMETH trial
NL-OMON60709Phase 4Recruiting
- Sponsor
- Erasmus MC
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in pulmonary sarcoidosis comparing Methotrexate with Prednisone (2 arms). Primary endpoint: Change in hospital-measured forced vital capacity. Started Nov 2024; status: recruiting.
02
Drugs
methotrexateprednisone
03
Conditions
pulmonary sarcoidosis
Beyond the preview
Go deeper on NL-OMON60709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60709.